ArticleCureus2025
Tube Flow Shunt: An Innovative and Cost-Effective Approach to the Modified Bleb-Forming Filtration Technique.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aiming to lower intraocular pressure, trabeculectomy remains the gold standard procedure. This report describes a novel, cost-effective modified bleb-forming filtration technique, tFlow (tube flow shunt), utilizing sterile trimmed silicone tubes from the Ahmed Glaucoma Valve (AGV), model FP7, to construct a subconjunctival filtration pathway. Here, clinical outcomes are not reported and will be evaluated in a future study. While initial findings suggest it may provide a viable alternative to other modified bleb-forming filtration techniques involving commercial devices like PreserFlo MicroShunt, EX-PRESS Glaucoma Filtration Device, and XEN Gel Stent, further investigation is necessary. Additional patient inclusion and comparative studies with different bleb-forming filtration techniques are potential areas for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.